182 related articles for article (PubMed ID: 24000244)
41. Metabolic characterization of 25X-NBOH and 25X-NBOMe phenethylamines based on UHPLC-Q-Exactive Orbitrap MS in human liver microsomes.
Xiang J; Wen D; Zhai W; Zhao J; Xiang P; Ma C; Shi Y
J Pharm Biomed Anal; 2024 May; 242():116020. PubMed ID: 38359493
[TBL] [Abstract][Full Text] [Related]
42. Synthesis and determination of analytical characteristics and differentiation of positional isomers in the series of N-(2-methoxybenzyl)-2-(dimethoxyphenyl)ethanamine using chromatography-mass spectrometry.
Kupriyanova OV; Shevyrin VA; Shafran YM; Lebedev AT; Milyukov VA; Rusinov VL
Drug Test Anal; 2020 Aug; 12(8):1154-1170. PubMed ID: 32415729
[TBL] [Abstract][Full Text] [Related]
43. Blunt Craniofacial Trauma as a Manifestation of Excited Delirium Caused by New Psychoactive Substances.
Byard RW; Cox M; Stockham P
J Forensic Sci; 2016 Nov; 61(6):1546-1548. PubMed ID: 27723094
[TBL] [Abstract][Full Text] [Related]
44. 25C-NBOMe and 25I-NBOMe metabolite studies in human hepatocytes, in vivo mouse and human urine with high-resolution mass spectrometry.
Wohlfarth A; Roman M; Andersson M; Kugelberg FC; Diao X; Carlier J; Eriksson C; Wu X; Konradsson P; Josefsson M; Huestis MA; Kronstrand R
Drug Test Anal; 2017 May; 9(5):680-698. PubMed ID: 27448631
[TBL] [Abstract][Full Text] [Related]
45. In Vitro Metabolism of 25B-NBF, 2-(4-Bromo-2,5-Dimethoxyphenyl)-
Kim JH; Kim S; Lee J; In S; Cho YY; Kang HC; Lee JY; Lee HS
Molecules; 2019 Feb; 24(4):. PubMed ID: 30823561
[TBL] [Abstract][Full Text] [Related]
46. Drug Recognition Evaluation and Chemical Confirmation of a 25C-NBOMe-Impaired Driver.
Rajotte JW; Palmentier JFP; Wallage HR
J Forensic Sci; 2017 Sep; 62(5):1410-1413. PubMed ID: 28261791
[TBL] [Abstract][Full Text] [Related]
47. Designer psychostimulants in urine by liquid chromatography-tandem mass spectrometry.
Kerrigan S; Mott A; Jatzlau B; Ortiz F; Perrella L; Martin S; Bryand K
J Forensic Sci; 2014 Jan; 59(1):175-83. PubMed ID: 24313279
[TBL] [Abstract][Full Text] [Related]
48. In vitro phase I metabolism of three phenethylamines 25D-NBOMe, 25E-NBOMe and 25N-NBOMe using microsomal and microbial models.
Grafinger KE; Stahl K; Wilke A; König S; Weinmann W
Drug Test Anal; 2018 Oct; 10(10):1607-1626. PubMed ID: 29971945
[TBL] [Abstract][Full Text] [Related]
49. Nano liquid chromatography-high-resolution mass spectrometry for the identification of metabolites of the two new psychoactive substances N-(ortho-methoxybenzyl)-3,4-dimethoxyamphetamine and N-(ortho-methoxybenzyl)-4-methylmethamphetamine.
Caspar AT; Meyer MR; Westphal F; Weber AA; Maurer HH
Talanta; 2018 Oct; 188():111-123. PubMed ID: 30029353
[TBL] [Abstract][Full Text] [Related]
50. Determination of four thiophenethylamine designer drugs (2C-T-series) in human plasma by capillary electrophoresis with mass spectrometry detection.
Boatto G; Nieddu M; Dessì G; Manconi P; Cerri R
J Chromatogr A; 2007 Aug; 1159(1-2):198-202. PubMed ID: 17098243
[TBL] [Abstract][Full Text] [Related]
51. Gas Chromatography Mass Spectrometry (GC-MS) for Identification of Designer Stimulants Including 2C Amines, NBOMe Compounds, and Cathinones in Urine.
Ketha H; Webb M; Clayton L; Li S
Curr Protoc Toxicol; 2017 Nov; 74():4.43.1-4.43.10. PubMed ID: 29117432
[TBL] [Abstract][Full Text] [Related]
52. Liquid chromatography-atmospheric pressure ionization electrospray mass spectrometry determination of "hallucinogenic designer drugs" in urine of consumers.
Pichini S; Pujadas M; Marchei E; Pellegrini M; Fiz J; Pacifici R; Zuccaro P; Farré M; de la Torre R
J Pharm Biomed Anal; 2008 Jun; 47(2):335-42. PubMed ID: 18262381
[TBL] [Abstract][Full Text] [Related]
53. Analytical characterization of four new ortho-methoxybenzylated amphetamine-type designer drugs.
Westphal F; Girreser U; Waldmüller D
Drug Test Anal; 2016 Sep; 8(9):910-9. PubMed ID: 26606897
[TBL] [Abstract][Full Text] [Related]
54. Severe poisoning after self-reported use of 2-(4-iodo-2,5-dimethoxyphenyl)-N-[(2-methoxyphenyl)methyl]ethanamine, a novel substituted amphetamine: a case series.
Hieger MA; Rose SR; Cumpston KL; Stromberg PE; Miller S; Wills BK
Am J Emerg Med; 2015 Dec; 33(12):1843.e1-3. PubMed ID: 25983267
[TBL] [Abstract][Full Text] [Related]
55. Rapid Screening Method for New Psychoactive Substances of Forensic Interest: Electrochemistry and Analytical Determination of Phenethylamines Derivatives (NBOMe) via Cyclic and Differential Pulse Voltammetry.
Andrade AF; Mamo SK; Gonzalez-Rodriguez J
Anal Chem; 2017 Feb; 89(3):1445-1452. PubMed ID: 28059498
[TBL] [Abstract][Full Text] [Related]
56. New designer drug 2,5-dimethoxy-4-ethylthio-beta-phenethylamine (2C-T-2): studies on its metabolism and toxicological detection in rat urine using gas chromatography/mass spectrometry.
Theobald DS; Staack RF; Puetz M; Maurer HH
J Mass Spectrom; 2005 Sep; 40(9):1157-72. PubMed ID: 16041763
[TBL] [Abstract][Full Text] [Related]
57. Determination of 32 cathinone derivatives and other designer drugs in serum by comprehensive LC-QQQ-MS/MS analysis.
Swortwood MJ; Boland DM; DeCaprio AP
Anal Bioanal Chem; 2013 Feb; 405(4):1383-97. PubMed ID: 23180084
[TBL] [Abstract][Full Text] [Related]
58. Metabolic Profile Determination of NBOMe Compounds Using Human Liver Microsomes and Comparison with Findings in Authentic Human Blood and Urine.
Temporal KH; Scott KS; Mohr ALA; Logan BK
J Anal Toxicol; 2017 Sep; 41(7):646-657. PubMed ID: 28472358
[TBL] [Abstract][Full Text] [Related]
59. Identification of Metabolite Biomarkers of the Designer Hallucinogen 25I-NBOMe in Mouse Hepatic Microsomal Preparations and Human Urine Samples Associated with Clinical Intoxication.
Poklis JL; Dempsey SK; Liu K; Ritter JK; Wolf C; Zhang S; Poklis A
J Anal Toxicol; 2015 Oct; 39(8):607-16. PubMed ID: 26378134
[TBL] [Abstract][Full Text] [Related]
60. The detection of NBOMe designer drugs on blotter paper by high resolution time-of-flight mass spectrometry (TOFMS) with and without chromatography.
Botch-Jones S; Foss J; Barajas D; Kero F; Young C; Weisenseel J
Forensic Sci Int; 2016 Oct; 267():89-95. PubMed ID: 27572638
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
